4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001415889-17-001378
EVP AND GC sold 14,322 shares at $34.88 ($499,534)
- EVP AND GC acquired 14,322 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Baity Glenn EVP AND GC | 2017-08-09 | Option exercise | +922 | $1.55 | $1,429 | 78,578 | D |
| Baity Glenn EVP AND GC | 2017-08-09 | Option exercise | +13,400 | $1.62 | $21,708 | 91,978 | D |
| Baity Glenn EVP AND GC | 2017-08-09 | Sale | −14,322 | $34.88 | $499,534 | 77,656 | D |
| Derivatives | |||||||
| Baity Glenn EVP AND GC | 2017-08-09 | Option exercise · Stock Option (right to buy) | −922 | 0 | D | ||
| Baity Glenn EVP AND GC | 2017-08-09 | Option exercise · Stock Option (right to buy) | −13,400 | 30,507 | D | ||
| Open-market sales · 14,322 sh · avg $34.88 · $499,534 | |||||||
Loading xslF345X03/form4-08112017_020820.xml…